Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 and traded as low as $5.28. Syros Pharmaceuticals shares last traded at $5.44, with a volume of 199,560 shares traded. Wall Street Analysts […]
StockNews.com lowered shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a hold rating to a sell rating in a research report released on Friday. Several other research firms also recently commented on SYRS. Piper Sandler reaffirmed an overweight rating and set a $13.00 price objective on shares of Syros Pharmaceuticals in a report on […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 1,740,000 shares, an increase of 31.8% from the February 29th total of 1,320,000 shares. Approximately 9.6% of the shares of the stock are short sold. Based […]
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. Syros Pharmaceuticals Price Performance Shares of NASDAQ SYRS traded down $0.10 during mid-day trading on Tuesday, reaching $6.46. The company had a […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 581,200 shares, a growth of 18.5% from the December 31st total of 490,600 shares. Based on an average daily trading volume, of 258,400 […]